Adenylyl cyclase type 5 protein expression during cardiac development and stress

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 5, 2009, Pages

  Hu, Che Lin ^a   Chandra, Rachna ^a   Ge, Hui ^a   Pain, Jayashree ^a   Yan, Lin ^a   Babu, Gopal ^a   Depre, Christophe ^a   Iwatsubo, Kousaku ^a   Ishikawa, Yoshihiro ^a   Sadoshima, Junichi ^a   Vatner, Stephen F ^a   Vatner, Dorothy E ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Adenylyl cyclase isoforms; Hypertrophy; Monoclonal antibody; Pressure overload

Indexed keywords

ADENYLATE CYCLASE; ADENYLATE CYCLASE 5; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AC5; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BETA ADRENERGIC STIMULATION; BRAIN TISSUE; CONTROLLED STUDY; HEART DEVELOPMENT; HEART LEFT VENTRICLE HYPERTROPHY; HEART STRESS; LIVER; LUNG; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOMACH; STRESS; SWINE; VASCULAR TISSUE;

ADENYLATE CYCLASE; AGE FACTORS; AGING; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CERCOPITHECUS AETHIOPS; COS CELLS; DISEASE MODELS, ANIMAL; DOGS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HYPERTROPHY, LEFT VENTRICULAR; ISOENZYMES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SWINE; TRANSFECTION;

EID: 70350448862     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00050.2009     Document Type: Article

References (32)

1. Agilent Technologies. Differences and similarities between the Protein 200 assay and SDS-PAGE: Technical Note, 2001 (http://www.chem.agilent.com/ Library/technicaloverviews/Public/59883160.pdf).
2. Bloch KD, Seidman JG, Naftilan JD, Fallon JT, Seidman CE. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell 47: 695-702, 1986.
3. Carlotti F, Zaldumbide A, Charif H, de Koning EJ, Luider TM, Hoeben RC. The 45-kDa form of Pdx-1 does not result from post-translational modifications. Biochem Biophys Res Commun 370: 225-229, 2008.
4. Defer N, Best-Belpomme M, Hanoune J. Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am J Physiol Renal Physiol 279: F400-F416, 2000.
5. Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, Stepkowski S, Davies PJ, Taegtmeyer H. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 4: 1269-1275, 1998. (Pubitemid 28512107)
6. Dessauer CW, Gilman AG. The catalytic mechanism of mammalian adenylyl cyclase. Equilibrium binding and kinetic analysis of P-site inhibition. J Biol Chem 272: 27787-27795, 1997.
7. Espinasse I, Iourgenko V, Defer N, Samson F, Hanoune J, Mercadier JJ. Type V, but not type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development. Correlation with increased global adenylyl cyclase activity. J Mol Cell Cardiol 27: 1789-1795, 1995.
8. Gu J, D'Andrea M, Seethapathy M. Atrial natriuretic peptide and its messenger ribonucleic acid in overloaded and overload-released ventricles of rat. Endocrinology 125: 2066-2074, 1989. (Pubitemid 19258644)
9. Huang C, Hepler JR, Chen LT, Gilman AG, Anderson RG, Mumby SM. Organization of G proteins and adenylyl cyclase at the plasma membrane. Mol Biol Cell 8: 2365-2378, 1997. (Pubitemid 27528207)
10. Ishikawa Y, Homcy CJ. The adenylyl cyclases as integrators of transmembrane signal transduction. Circ Res 80: 297-304, 1997. (Pubitemid 27093342)
11. Ishikawa Y, Katsushika S, Chen L, Halnon NJ, Kawabe J, Homcy CJ. Isolation and characterization of a novel cardiac adenylylcyclase cDNA. J Biol Chem 267: 13553-13557, 1992.
12. Iyengar R. Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases. FASEB J 7: 768-775, 1993. (Pubitemid 23199535)
13. Izumo S, Nadal-Ginard B, Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85: 339-343, 1988.
14. Jassen AK, Brown JM, Panas HN, Miller GM, Xiao D, Madras BK. Variants of the primate vesicular monoamine transporter-2. Brain Res Mol Brain Res 139: 251-257, 2005. (Pubitemid 41317938)
15. Knowlton KU, Rockman HA, Itani M, Vovan A, Seidman CE, Chien KR. Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium. J Clin Invest 96: 1311-1318, 1995.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
17. Lane RD, Crissman RS, Ginn S. High efficiency fusion procedure for producing monoclonal antibodies against weak immunogens. Methods Enzymol 121: 183-192, 1986. (Pubitemid 16057893)
18. Li LB, Chen N, Ramamoorthy S, Chi L, Cui XN, Wang LC, Reith ME. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J Biol Chem 279: 21012-21020, 2004. (Pubitemid 38656502)
19. Matsuoka I, Suzuki Y, Defer N, Nakanishi H, Hanoune J. Differential expression of type I, II, and V adenylyl cyclase gene in the postnatal developing rat brain. J Neurochem 68: 498-506, 1997. (Pubitemid 27044708)
20. Okumura S, Kawabe J, Yatani A, Takagi G, Lee MC, Hong C, Liu J, Takagi I, Sadoshima J, Vatner DE, Vatner SF, Ishikawa Y. Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation. Circ Res 93: 364-371, 2003. (Pubitemid 37048249)
21. Okumura S, Takagi G, Kawabe J, Yang G, Lee MC, Hong C, Liu J, Vatner DE, Sadoshima J, Vatner SF, Ishikawa Y. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci USA 100: 9986-9990, 2003. (Pubitemid 37087055)
22. Okumura S, Vatner DE, Kurotani R, Bai Y, Gao S, Yuan Z, Iwatsubo K, Ulucan C, Kawabe J, Ghosh K, Vatner SF, Ishikawa Y. Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress. Circulation 116: 1776-1783, 2007. (Pubitemid 350287102)
23. Phan HM, Gao MH, Lai NC, Tang T, Hammond HK. New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy. Trends Cardiovasc Med 17: 215-221, 2007. (Pubitemid 47532726)
24. Robishaw JD, Smigel MD, Gilman AG. Molecular basis for two forms of the G protein that stimulates adenylate cyclase. J Biol Chem 261: 9587-9590, 1986.
25. Sadoshima J, Montagne O, Wang Q, Yang G, Warden J, Liu J, Takagi G, Karoor V, Hong C, Johnson GL, Vatner DE, Vatner SF. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J Clin Invest 110: 271-279, 2002. (Pubitemid 34787364)
26. Scarpace PJ, Matheny M, Tumer N. Myocardial adenylyl cyclase type V and VI mRNA: differential regulation with age. J Cardiovasc Pharmacol 27: 86-90, 1996. (Pubitemid 26010644)
27. Tang T, Gao MH, Lai NC, Firth AL, Takahashi T, Guo T, Yuan JX, Roth DM, Hammond HK. Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling. Circulation 117: 61-69, 2008. (Pubitemid 350291182)
28. --dependent serotonin transporter expressed using recombinant baculovirus in insect cells. J Biol Chem 269: 26303-26310, 1994.
29. Tesmer JJ, Sunahara RK, Gilman AG, Sprang SR. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha. GTPgammaS. Science 278: 1907-1916, 1997.
30. Tobise K, Ishikawa Y, Holmer SR, Im MJ, Newell JB, Yoshie H, Fujita M, Susannie EE, Homcy CJ. Changes in type VI adenylyl cyclase isoform expression correlate with a decreased capacity for cAMP generation in the aging ventricle. Circ Res 74: 596-603, 1994. (Pubitemid 24088520)
31. Wang T, Brown MJ. Differential expression of adenylyl cyclase subtypes in human cardiovascular system. Mol Cell Endocrinol 223: 55-62, 2004. (Pubitemid 38992910)
32. Yan L, Vatner DE, O'Connor JP, Ivessa A, Ge H, Chen W, Hirotani S, Ishikawa Y, Sadoshima J, Vatner SF. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 130: 247-258, 2007. (Pubitemid 47081133)